SofWave Medical Ltd. (SOFW.TA)
ILA 1675.0
(-1.47%)
ILA 1675.0
(-1.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -6.3 Million | -10.69 Million | -2.09 Million | -4.8 Million | -2.95 Million |
| Net Income | -8.27 Million | -19.52 Million | -6.82 Million | -11.68 Million | -3.44 Million |
| Depreciation & Amortization | 1.5 Million | 1.11 Million | 359 Thousand | 65 Thousand | 17 Thousand |
| Deferred income taxes | -21 Thousand | 2.22 Million | -321 Thousand | 4.7 Million | -100 Thousand |
| Stock-based compensation | 2.27 Million | 5.13 Million | 5.03 Million | 1.93 Million | 199 Thousand |
| Change in working capital | -1.1 Million | 384 Thousand | -699 Thousand | -122 Thousand | 140 Thousand |
| Other non-cash items | -684 Thousand | -28 Thousand | 355 Thousand | 301 Thousand | 233 Thousand |
| Investing Cash Flow | 409 Thousand | -260 Thousand | -982 Thousand | -263 Thousand | -4000.00 |
| Investments in PPE | -407 Thousand | -447 Thousand | -821 Thousand | -263 Thousand | -1000.00 |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -59 Thousand | -143 Thousand | -161 Thousand | - | -3000.00 |
| Sales/Maturities of investments | 98 Thousand | - | - | - | - |
| Other Investing Activities | 777 Thousand | 330 Thousand | -130 Thousand | 14 Thousand | -3000.00 |
| Financing Cash Flow | -1.72 Million | -1.34 Million | 46.64 Million | 1.99 Million | 8.39 Million |
| Debt repayment | -648 Thousand | -689 Thousand | -213 Thousand | -32 Thousand | -16 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 4000.00 | 30 Thousand | 46.96 Million | 2.06 Million | - |
| Other Financing Activities | -1.72 Million | -688 Thousand | -103 Thousand | -38 Thousand | 8.41 Million |
| Accounts receivables | -3.32 Million | 1.72 Million | -4.85 Million | -1.31 Million | 66 Thousand |
| Accounts payables | - | -1.72 Million | 4.85 Million | 1.31 Million | -66 Thousand |
| Inventory | -1.62 Million | -3.05 Million | -1.9 Million | -61 Thousand | -54 Thousand |
| Other working capital | 517 Thousand | 3.44 Million | 1.2 Million | -61 Thousand | 194 Thousand |
| Cash at beginning of period | 32 Million | 46.2 Million | 2.64 Million | 5.71 Million | 132 Thousand |
| Cash at end of period | 24.42 Million | 32 Million | 46.2 Million | 2.64 Million | 5.71 Million |
| Capital Expenditure | -407 Thousand | -447 Thousand | -821 Thousand | -263 Thousand | -1000.00 |
| Effect of forex changes on cash | 37 Thousand | -1.9 Million | 2.27 Million | - | 146 Thousand |
| Net cash flow / Change in cash | -7.58 Million | -14.2 Million | 43.56 Million | -3.07 Million | 5.58 Million |
| Free Cash Flow | -6.71 Million | -11.14 Million | -2.91 Million | -5.06 Million | -2.95 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.53 Million | -983 Thousand | -8.27 Million | -375 Thousand | -1.23 Million | -2.83 Million |
| Depreciation & Amortization | 397 Thousand | 406 Thousand | 1.5 Million | 391 Thousand | 331 Thousand | 345 Thousand |
| Deferred income taxes | - | - | -21 Thousand | - | -376 Thousand | 90 Thousand |
| Stock-based compensation | 658 Thousand | 512 Thousand | 2.27 Million | 419 Thousand | 483 Thousand | 644 Thousand |
| Change in working capital | -1.04 Million | -1.06 Million | -1.1 Million | -2.67 Million | -277 Thousand | -1.24 Million |
| Other non-cash items | -184 Thousand | -131 Thousand | -684 Thousand | 2.96 Million | -330.99 Thousand | -269 Thousand |
| Investing Cash Flow | 61 Thousand | 74 Thousand | 409 Thousand | 121 Thousand | 200 Thousand | 247 Thousand |
| Investments in PPE | -107 Thousand | -70 Thousand | -407 Thousand | -41 Thousand | -90 Thousand | -76 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -13 Thousand | -8000.00 | -59 Thousand | - | - | - |
| Sales/Maturities of investments | 8000.00 | - | 98 Thousand | - | - | 4000.00 |
| Other Investing Activities | 173 Thousand | 144 Thousand | 777 Thousand | 162 Thousand | 290 Thousand | 323 Thousand |
| Financing Cash Flow | -396 Thousand | -156 Thousand | -1.72 Million | -822 Thousand | -164 Thousand | -572 Thousand |
| Debt repayment | -157 Thousand | -158 Thousand | -648 Thousand | -155 Thousand | -166 Thousand | -162 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 43 Thousand | 2000.00 | 4000.00 | - | - | - |
| Other Financing Activities | -282 Thousand | 2000.00 | -1.72 Million | -667 Thousand | 2000.00 | -410 Thousand |
| Accounts receivables | -746 Thousand | 898 Thousand | -3.32 Million | -1.69 Million | -95 Thousand | -1.5 Million |
| Accounts payables | - | - | - | - | - | 1.5 Million |
| Inventory | -74 Thousand | -466 Thousand | -1.62 Million | -873 Thousand | -12 Thousand | 26 Thousand |
| Other working capital | -221 Thousand | -737 Thousand | 517 Thousand | -115 Thousand | -170 Thousand | -1.27 Million |
| Cash at beginning of period | 23.1 Million | 24.42 Million | 32 Million | 24.29 Million | 25.3 Million | 28.99 Million |
| Cash at end of period | 21.08 Million | 23.1 Million | 24.42 Million | 24.42 Million | 24.29 Million | 25.3 Million |
| Capital Expenditure | -107 Thousand | -70 Thousand | -407 Thousand | -41 Thousand | -90 Thousand | -76 Thousand |
| Effect of forex changes on cash | -31 Thousand | 26 Thousand | 37 Thousand | 110 Thousand | -20 Thousand | -90 Thousand |
| Net cash flow / Change in cash | -2.02 Million | -1.31 Million | -7.58 Million | 128 Thousand | -1.01 Million | -3.68 Million |
| Free Cash Flow | -1.76 Million | -1.32 Million | -6.71 Million | 678 Thousand | -1.11 Million | -3.34 Million |
DELT
7709
IRIS
MGRO
ALRGR
EXPLEOSOL